Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis September ...

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to ...

The way you speak may carry hidden fingerprints of cognitive decline, and a sweeping new analysis of a decade of research suggests those fingerprints could soon be read by machines. A scoping review ...

Mount Sinai researchers have identified how APOE4, the strongest genetic risk factor for Alzheimer's disease, damages the brain's blood vessels and promotes the buildup of abnormal proteins linked to ...

For a long time, dementia research has been shaped by concerns that participation may be too burdensome for people with ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the ...

The demands of caregiving can reverberate through family relationships, exposing old disagreements about expectations and responsibilities.

Every National Plan goal should have an accountable agency, annual funding disclosure, numerical performance target, and deadline, with results reported to Congress and the public each year.

This year’s World Alzheimer’s Day theme is “The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters,” observed September 21, 2026, bringing attention to the disease and the importance ...

Navigating Alzheimer's Agitation survey finds that Alzheimer's disease agitation is often only recognized after daily life is ...

ABU DHABI, 21st September, 2026 (WAM) -- Policymakers, clinicians and healthcare leaders from across the Gulf have called for health systems to establish connected Alzheimer’s disease care pathways so ...